{
    "title": "Gilead shares slide after FDA knocks back rheumatoid arthritis drug",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8643443/Gilead-shares-slide-FDA-knocks-rheumatoid-arthritis-drug.html",
    "date": "2020-08-19",
    "keywords": [
        "drug",
        "filgotinib",
        "arthritis",
        "treatment",
        "year",
        "galapagos",
        "profile",
        "analyst",
        "note",
        "class",
        "jak",
        "food",
        "administration",
        "setback",
        "medicine",
        "remdesivir",
        "company",
        "forefront",
        "fight",
        "move",
        "expansion",
        "partnership",
        "belgodutch",
        "biotech",
        "nv",
        "banking",
        "potential",
        "development",
        "gilead",
        "morning",
        "trade",
        "response",
        "letter",
        "fda",
        "benefitrisk",
        "mg",
        "dose",
        "review",
        "jp",
        "cory",
        "kasimov",
        "peak",
        "request",
        "approval",
        "lack",
        "flexibility",
        "fix",
        "program",
        "rheumatoid",
        "risk",
        "credit",
        "evan",
        "seigerman",
        "range",
        "autoimmune",
        "lillys",
        "olumiant",
        "inhibitor",
        "efficacy",
        "overhang",
        "safety",
        "tolerability",
        "guggenheim",
        "reporting",
        "trisha",
        "roy",
        "ankur",
        "banerjee",
        "bengaluru",
        "editing",
        "krauskopf",
        "maju",
        "samuel"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}